{"timestamp": 1771600263.8349133, "value": {"ticker": "GTBP", "company_name": "GT Biopharma, Inc.", "short_name": "GT Biopharma, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 12630474, "float_shares": 10303011, "shares_outstanding": 26652194, "short_ratio": 1.77, "short_percent_of_float": 0.1011, "shares_short": 2691277, "shares_short_prior": 2111313, "insider_percent_held": 0.02736, "institution_percent_held": 0.030840002, "total_cash": 2528000, "total_debt": 0, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 0, "current_ratio": 3.271, "book_value": 0.496, "price_to_book": 0.95544356, "operating_cashflow": -11361000, "free_cashflow": -11017750, "price": 0.4739, "52w_high": 3.85, "52w_low": 0.401, "avg_volume": 1585726, "avg_volume_10d": 1943520, "full_time_employees": 1, "audit_risk": 0, "overall_risk": 0}}